China SXT Pharmaceuticals Announces 1-for-100 Reverse Stock Split
China SXT Pharmaceuticals, Inc. announced it will implement a 1-for-100 reverse stock split of its Class A ordinary shares, effective October 26, 2026.
Stocks · News reference
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
China SXT Pharmaceuticals, Inc. announced it will implement a 1-for-100 reverse stock split of its Class A ordinary shares, effective October 26, 2026.
China SXT Pharmaceuticals, Inc. has terminated the right of purchasers to acquire up to an additional $12 million in shares or pre-funded warrants from its October 8, 2026, registered direct offering.
U.S. stocks mixed: Dow rose 0.43%, while Nasdaq and S&P 500 fell. GE raised its forecast; oil gained and gold declined.
3M shares rose 4.4% premarket after expanding its Amazon data-center deal, including a $521.4M stock warrant; other stocks saw sharp moves.
U.S. stock futures were swinging between gains and losses on Tuesday, as the Dow Jones and S&P 500 indices rose, while the Nasdaq 100 fell.
U.S. stocks traded mixed: Dow rose 0.47%, S&P 500 edged up, Nasdaq fell; energy led gains, while Chipotle dropped after Starbucks denied takeover rumors.